Genmab Files Annual Report with the U.S. Securities and Exchange Commission
16/2 20:14
Media Release Copenhagen, Denmark, February 16, 202 2 Genmab filed Form 20-F for the financial year 202 1 with the U.S. SEC Genmab A/S (Nasdaq: GMAB) announced today that it has filed its Annual Report for the financial year 202 1 on Form 20-F with the U.S....